Victory Capital Management
DGX icon

Victory Capital Management’s Quest Diagnostics DGX Stock Holding History

Victory Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$362M Sell
1,846,336
-280,086
-13% -$54.4M 0.23% 92
2025
Q4 		$369M Sell
2,126,422
-217,552
-9% -$39.6M 0.21% 105
2025
Q3 		$447M Sell
2,343,974
-465,252
-17% -$82.6M 0.26% 76
2025
Q2 		$505M Sell
2,809,226
-324,301
-10% -$56.3M 0.33% 60
2025
Q1 		$530M Sell
3,133,527
-226,459
-7% -$37.2M 0.54% 19
2024
Q4 		$507M Sell
3,359,986
-104,370
-3% -$16.2M 0.5% 20
2024
Q3 		$538M Sell
3,464,356
-419,365
-11% -$62.6M 0.52% 19
2024
Q2 		$532M Sell
3,883,721
-38,610
-1% -$5.29M 0.53% 17
2024
Q1 		$522M Buy
3,922,331
+445,703
+13% +$57.8M 0.51% 20
2023
Q4 		$479M Buy
3,476,628
+62,114
+2% +$8.17M 0.5% 17
2023
Q3 		$416M Buy
3,414,514
+180,889
+6% +$24.1M 0.48% 25
2023
Q2 		$455M Buy
3,233,625
+97,425
+3% +$13.4M 0.5% 16
2023
Q1 		$444M Sell
3,136,200
-122,265
-4% -$17.5M 0.5% 20
2022
Q4 		$510M Buy
3,258,465
+34,947
+1% +$5.02M 0.59% 9
2022
Q3 		$395M Buy
3,223,518
+210,961
+7% +$27.8M 0.46% 17
2022
Q2 		$401M Buy
3,012,557
+124,942
+4% +$17M 0.46% 20
2022
Q1 		$394M Buy
2,887,615
+335,762
+13% +$46.8M 0.39% 38
2021
Q4 		$441M Sell
2,551,853
-287,409
-10% -$43.7M 0.41% 24
2021
Q3 		$413M Sell
2,839,262
-325,979
-10% -$47.7M 0.4% 26
2021
Q2 		$418M Buy
3,165,241
+240,413
+8% +$31.5M 0.4% 23
2021
Q1 		$375M Buy
2,924,828
+407,180
+16% +$50.2M 0.38% 23
2020
Q4 		$300M Buy
2,517,648
+55,410
+2% +$6.75M 0.33% 34
2020
Q3 		$282M Sell
2,462,238
-216,793
-8% -$25.6M 0.36% 34
2020
Q2 		$305M Sell
2,679,031
-4,380,995
-62% -$465M 0.41% 16
2020
Q1 		$567M Buy
7,060,026
+3,030,537
+75% +$314M 0.48% 16
2019
Q4 		$430M Buy
4,029,489
+212,706
+6% +$22.2M 0.52% 10
2019
Q3 		$409M Buy
3,816,783
+628,715
+20% +$64.5M 0.53% 9
2019
Q2 		$325M Buy
3,188,068
+344,767
+12% +$33.1M 0.65% 6
2019
Q1 		$256M Buy
2,843,301
+32,264
+1% +$2.8M 0.58% 14
2018
Q4 		$234M Buy
2,811,037
+135,312
+5% +$12.7M 0.59% 15
2018
Q3 		$289M Buy
2,675,725
+111,200
+4% +$12.2M 0.6% 8
2018
Q2 		$282M Buy
2,564,525
+127,232
+5% +$13.3M 0.6% 10
2018
Q1 		$244M Sell
2,437,293
-50,002
-2% -$5.12M 0.53% 12
2017
Q4 		$245M Buy
2,487,295
+560,538
+29% +$53.1M 0.52% 19
2017
Q3 		$180M Buy
1,926,757
+343,399
+22% +$36.5M 0.41% 37
2017
Q2 		$176M Sell
1,583,358
-315,702
-17% -$33.4M 0.41% 33
2017
Q1 		$186M Sell
1,899,060
-23,634
-1% -$2.25M 0.44% 15
2016
Q4 		$177M Buy
1,922,694
+133,891
+7% +$11.5M 0.45% 13
2016
Q3 		$151M Buy
1,788,803
+530,043
+42% +$44.5M 0.42% 16
2016
Q2 		$102M Buy
1,258,760
+1,250,766
+15,646% +$95.2M 0.41% 35
2016
Q1 		$571K Sell
7,994
-4,801
-38% -$322K ﹤0.01% 1020
2015
Q4 		$910K Buy
12,795
+2,184
+21% +$147K ﹤0.01% 841
2015
Q3 		$652K Buy
10,611
+4
+0% +$280 ﹤0.01% 907
2015
Q2 		$772K Buy
+10,607
New +$783K ﹤0.01% 859

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Victory Capital Management's DGX Position: Q1 2026 in Review

Victory Capital Management reduced its Quest Diagnostics (DGX) stake by 13% in Q1 2026, selling an estimated $54.4M and leaving 1,846,336 shares worth $362M. The position accounts for 0.23% of the portfolio, ranked #92.

Victory Capital Management first reported a position in DGX in Q2 2015 and has held it in 44 quarters since. The position peaked at $567M in Q1 2020. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Victory Capital Management held 1,846,336 shares of Quest Diagnostics worth $362M as of Q1 2026.
  • Victory Capital Management sold 280,086 Quest Diagnostics shares in Q1 2026, an estimated $54.4M.
  • Quest Diagnostics made up 0.23% of Victory Capital Management's portfolio in Q1 2026, its #92 holding.
  • Victory Capital Management first reported a position in Quest Diagnostics in Q2 2015 and has held it in 44 quarters since.
  • Victory Capital Management's Quest Diagnostics position peaked at $567M in Q1 2020.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.